May 3, 2026
InsightOzempic and the Quiet Drinker: What I See in Executive Cases
The press has decided GLP-1 medications are the next fix for executive drinking. The clinical reality I see is more uneven. A clinical recovery read on what the 2026 trials actually show, where the medication helps, and where it does not.
Read Briefing →